Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
668
datasets available to search
ShareScore release 0.9.0
Dataset results
668 results for “Everolimus”
Activity and Safety of Everolimus+Octreotide LAR+Metformin in Advanced Pancreatic Well-differentiated NETs
ClinicalTrials.gov study NCT02294006. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Efficacy and Safety of Everolimus in de Novo Heart Transplant Recipients
ClinicalTrials.gov study NCT00150046. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Comparison of a Contemporary Sirolimus-eluting Stent (ihtDEStiny®) With Another Everolimus-eluting Stent (Xience™), Both With Permanent Polymers, in Patients With Acute Coronary Syndrome and de Novo C
ClinicalTrials.gov study NCT07190690. IPD Sharing: Not stated. Countries: 1. Publications: 5.
Comparison of Titanium-Nitride-Oxide Coated Bio-Active-Stent (Optimax™) to the Drug (Everolimus) -Eluting Stent (Synergy™) in Acute Coronary Syndrome
ClinicalTrials.gov study NCT02049229. IPD Sharing: Not stated. Countries: 1. Publications: 3.
SEA-SIDE: Sirolimus Versus Everolimus-eluting Stent Randomized Assessment in Bifurcated Lesions and Clinical SIgnificance of Residual siDE-branch Stenosis
ClinicalTrials.gov study NCT00697372. IPD Sharing: Not stated. Countries: 1. Publications: 16.
Analysis of Tumor Tissue and Circulating Genetic Material in the Blood to Obtain Further Insight in the Effectiveness of Everolimus When Combined With Exemestane
ClinicalTrials.gov study NCT02109913. IPD Sharing: Not stated. Countries: 1. Publications: 3.
ABSORB Clinical Investigation, Cohort A (ABSORB A) Everolimus Eluting Coronary Stent System Clinical Investigation
ClinicalTrials.gov study NCT00300131. IPD Sharing: Not stated. Countries: 4. Publications: 16.
Influence of Exceptional Patient Characteristics on Everolimus Exposure
ClinicalTrials.gov study NCT01948960. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Efficacy and Safety of Radiotherapy Compared to Everolimus in Somatostatin Receptor Positive Neuroendocrine Tumors of the Lung and Thymus.
ClinicalTrials.gov study NCT05918302. IPD Sharing: NO. Countries: 4. Publications: 1.
Study to Evaluate the Safety and Efficacy of Everolimus, in Subjects With PIK3CA Amplification, PTEN Loss and PIK3CA Mutation Refractory Solid Tumors
ClinicalTrials.gov study NCT02449538. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Everolimus in Treating Patients With Progressive or Recurrent, Unresectable, or Metastatic Thyroid Cancer
ClinicalTrials.gov study NCT01118065. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Everolimus in Treating Patients With Relapsed or Metastatic Endometrial Cancer
ClinicalTrials.gov study NCT00870337. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Randomized Comparison of Abluminus DES+ Sirolimus-Eluting Stents Versus Everolimus-Eluting Stents in Coronary Artery Disease Patients With Diabetes Mellitus Global
ClinicalTrials.gov study NCT04236609. IPD Sharing: NO. Countries: 21. Publications: 24.
Certican® (Everolimus) Against Cytomegalovirus Disease in Renal Transplant Patients
ClinicalTrials.gov study NCT00828503. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Everolimus as First-Line Therapy in Treating Patients With Prostate Cancer
ClinicalTrials.gov study NCT00976755. IPD Sharing: NO. Countries: 1. Publications: 1.
Open Label, Single Arm Trial to Characterize Patients With Metastatic RCC Treated With Everolimus After Failure of the First VEGF-targeted Therapy (MARC-2)
ClinicalTrials.gov study NCT01266837. IPD Sharing: NO. Countries: 1. Publications: 1.
Efficacy Study of Sunitinib and Everolimus (Rotational vs Sequential Arm) in Pats. With m Clear Cell Renal Cancer
ClinicalTrials.gov study NCT01784978. IPD Sharing: Not stated. Countries: 3. Publications: 1.
Study of GDC-0980 Versus Everolimus in Participants With Metastatic Renal Cell Carcinoma Who Have Progressed on or Following Vascular Endothelial Growth Factor- (VEGF) Targeted Therapy
ClinicalTrials.gov study NCT01442090. IPD Sharing: Not stated. Countries: 5. Publications: 1.
Study to Compare Vinorelbine In Combination With the mTOR Inhibitor Everolimus vs. Vinorelbin Monotherapy for Second-line Treatment in Advanced Breast Cancer
ClinicalTrials.gov study NCT01520103. IPD Sharing: Not stated. Countries: 1. Publications: 1.
The Impact of Everolimus Based Immunosuppression in the Evolution of Hepatitis C Fibrosis After Liver Transplantation
ClinicalTrials.gov study NCT01707849. IPD Sharing: NO. Countries: 1. Publications: 23.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.